KNG1 and COVID-19: Both the original proposals about the potential involvement of the bradykinin system in COVID‐19 pathology (Roche & Roche, 2020; van de Veerdonk et al., 2020) and the recent gene expression analysis study conducted by Garvin and colleagues (Garvin et al., 2020) did an elegant job in explaining the close association of bradykinin with the RAS and linking it to many of the COVID‐19 outcomes.